LIVE: FDA Advisory Committee Meets on Compounded Drug Substances (DAY 2)

The FDA’s Pharmacy Compounding Advisory Committee meets at 8 a.m. ET on July 24 to discuss several bulk drug substances being considered for inclusion on the 503A bulks list, including BPC-157, KPV, TB-500, and MOTs-C. The committee will also hear presentations from nominators supporting the proposed substances.